A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2011
10/06/2011	US20110245213 Treatment
10/06/2011	US20110245212 Methods of alleviating the symptoms of premenstrual syndrome/late luteal phase dysphoric disorder
10/06/2011	US20110245211 Method for contraception
10/06/2011	US20110245210 Thalidomide analogs
10/06/2011	US20110245209 Pyridopyrimidine derivatives and methods of use thereof
10/06/2011	US20110245208 Compositions and methods for the treatment of somatosensory disorders
10/06/2011	US20110245207 Method for moderately increasing the proton conductivity of biological membranes with the aid of mitochondria-targeted delocalized cations
10/06/2011	US20110245206 Antioxidant inflammation modulators: c-17 homologated oleanolic acid derivatives
10/06/2011	US20110245205 Aminopyrimidines as syk inhibitors
10/06/2011	US20110245204 Cycloalkane-containing sphingosine 1-phosphate agonists
10/06/2011	US20110245203 Derivatives of 1-amino-2-cyclopropylethylboronic acid
10/06/2011	US20110245202 Pharmaceutical composition for the treatment of rhinitis
10/06/2011	US20110245201 Treatment of cancer
10/06/2011	US20110245200 Use of idrabiotaparinux for decreasing the incidence of bleedings during an antithrombotic treatment
10/06/2011	US20110245199 Sulfated Depolymerized Derivatives of Expolysaccharides (Eps) from Mesophilic Marine Bacteria, Method for Preparing the Same, and Uses Thereof in Tissue Regeneration
10/06/2011	US20110245198 Enhanced treatments to kill or debilitate pathogenic microorganisms of a mammalian body
10/06/2011	US20110245197 Hypersulfated glucopyranosides
10/06/2011	US20110245196 Novel sulfated oligosaccharide derivatives
10/06/2011	US20110245195 Method of reducing intraocular pressure in humans
10/06/2011	US20110245194 Adenosine compounds and their use thereof
10/06/2011	US20110245193 Combination compositions for reducing intraocular pressure
10/06/2011	US20110245192 New activators for treating and/or preventing diseases or medical conditions which benefit from an increased transport of hyaluronan across a lipid bilayer
10/06/2011	US20110245191 Parasiticidal compositions comprising multiple active agents, methods and uses thereof
10/06/2011	US20110245190 Method for improving post surgery visual acuity outcome with azithromycin
10/06/2011	US20110245189 Composition and method for the treatment of eye disease
10/06/2011	US20110245188 Methods and compositions for the prevention and treatment of inflammatory diseases or conditions
10/06/2011	US20110245186 Recombinant e-selectin made in insect cells
10/06/2011	US20110245179 Composition for Prevention or Treatment of Heart Failure
10/06/2011	US20110245177 Method for topical treatment of eye disease and composition and device for said treatment
10/06/2011	US20110245172 Biocompatible oligomer-polymer compositions
10/06/2011	US20110245158 High Protein Supplement
10/06/2011	US20110245156 Novel antiviral compounds, compositions, and methods of use
10/06/2011	US20110245154 Methods and Compositions for Treating Viral or Virally-Induced Conditions
10/06/2011	US20110245150 Targets for treatment of chlamydial infections
10/06/2011	US20110245149 Methods to prevent and treat diseases
10/06/2011	US20110245148 Acetic acid and a buffer
10/06/2011	US20110245145 Methods and reagents for the diagnosis, prevention and treatment of insulin resistance
10/06/2011	US20110244568 Rna sequence-specific mediators of rna interference
10/06/2011	US20110244446 Rna sequence-specific mediators of rna interference
10/06/2011	US20110244062 Multiplication of the efficacy of anti-infectious agents by a composition comprising an extract made from dehydrated and partially sodium-free seawater
10/06/2011	US20110244059 Inhibiting obesity progression by inhibiting adipocyte differentiation with a pre-adipocyte autophagy inhibitor
10/06/2011	US20110244058 Compositions and methods for treatment of pulmonary diseases and conditions
10/06/2011	US20110244057 Combination therapies with topiramate for seizures, restless legs syndrome, and other neurological conditions
10/06/2011	US20110244055 Compositions and methods for promoting appetite suppression using alkali metals
10/06/2011	US20110244052 Polyunsaturated fatty acids for improving vision
10/06/2011	US20110244051 Pharmaceutical formulations for the treatment of overactive bladder
10/06/2011	US20110244050 Pulsed-release sildenafil composition and method for preparing said composition
10/06/2011	US20110244049 Compositions comprising 4-(2-(5-bromo-4-(1-cyclopropylnaphthalen-4-yl)-4h-1,2,4-triazol-3-ylthio)acetamido)-3-chlorobenzoic acid and pharmaceutically acceptable salts thereof, and methods for preparing and using same
10/06/2011	US20110244048 Multifunctional self-assembling polymeric nanosystems
10/06/2011	US20110244047 Film-form preparation and method for producing the same
10/06/2011	US20110244045 Controlled release of n-acetylcysteine (nac) for reduction of systemic and/or vascular inflammation
10/06/2011	US20110244044 Compound, medicament, vaccine composition and nanocapsules
10/06/2011	US20110244043 Controlled releasing composition
10/06/2011	US20110244042 Stabilized formulations of cns compounds
10/06/2011	US20110244040 Film-coated scored tablet
10/06/2011	US20110244037 Pharmaceutical composition comprising a bi-cyclic compound and method for stabilizing the bi-cyclic compound
10/06/2011	US20110244036 Pharmaceutical composition comprising a bi-cyclic compound and method for stabilizing the bi-cyclic compound
10/06/2011	US20110244035 Dosage Forms
10/06/2011	US20110244034 Sustained release drug delivery system
10/06/2011	US20110244033 Tamsulosin pellets for fixed dose combination
10/06/2011	US20110244032 Dispersible phospholipid stabilized microparticles
10/06/2011	US20110244031 Porous tablets as carriers for liquid formulations
10/06/2011	US20110244029 Composition of matter comprising liposomes embedded in a polymeric matrix and methods of using same
10/06/2011	US20110244028 Method of solubilizing biologically active compounds
10/06/2011	US20110244027 2'-Fluoro-6'-Methylene Carbocyclic Nucleosides and Methods of Treating Viral Infections
10/06/2011	US20110244024 Microrna compositions and methods for the treatment of myelogenous leukemia
10/06/2011	US20110244022 Transdermal delivery patch
10/06/2011	US20110244020 Drug condensation aerosols and kits
10/06/2011	US20110244017 Absorbable Coating For Implantable Device
10/06/2011	US20110244016 Medical implant having a coating composed of or containing at least one active substance
10/06/2011	US20110244004 Antifungal composition with enhanced bioavailability
10/06/2011	US20110244002 Mesoporous material excipients for poorly aqueous soluble ingredients
10/06/2011	US20110244001 System and method for the release of nitric oxide using nanoscale media
10/06/2011	US20110243999 Methods and compositions for the treatment of ocular disorders
10/06/2011	US20110243998 Patch preparation and production method thereof
10/06/2011	US20110243997 Film-form preparation and method for producing the same
10/06/2011	US20110243985 Self-adhesive matrix system comprising a styrene block copolymer
10/06/2011	US20110243968 Therapeutic applications of p53 isoforms in regenerative medicine, aging and cancer
10/06/2011	US20110243964 Treatment of orthopedic conditions
10/06/2011	US20110243959 Modulating neuronal plasticity and treatment of neuronal loss by modulationg wnt7a or wnt7b modulation
10/06/2011	US20110243957 Materials and methods for preventing or treating neurodegenerative conditions associated with abeta peptide accumulation
10/06/2011	US20110243956 Methods of diagnosing and treating complications of pregnancy
10/06/2011	US20110243955 Antibody and uses thereof
10/06/2011	US20110243940 Bicyclic pyranone derivatives and methods of use thereof
10/06/2011	US20110243939 Modification of nucleic acid vectors with polymers comprising charged quaternary amino groups
10/06/2011	US20110243938 Methods to Reduce B-Helper T Cells to Treat Autoimmune Diseases
10/06/2011	US20110243937 Targeting pax2 for the treatment of breast cancer
10/06/2011	US20110243933 Perifosine and Capecitabine as a Combined Treatment for Cancer
10/06/2011	US20110243930 Compositions and methods for the treatment of immune related diseases
10/06/2011	US20110243927 Methods of inhibiting tumor growth using beta 5 integrin antagonists
10/06/2011	US20110243924 Novel methods
10/06/2011	US20110243923 Organic compounds
10/06/2011	US20110243922 Genetic Alterations Associated with Type I Diabetes and Methods of Use Thereof for Diagnosis and Treatment
10/06/2011	US20110243917 Composition for the prevention and treatment of absence seizures comprising pkc agonist as an effective ingredient
10/06/2011	US20110243914 Shiga toxin b-subunit as a vector for tumor diagnosis and drug delivery to gb3 expressing tumors
10/06/2011	US20110243911 Use of a compound capable of reducing the uric acid level for the prevention and/or the treatment of lung inflammation and fibrosis
10/06/2011	US20110243907 Cosmetic and nutritional alpha-omega complex composition
10/06/2011	US20110243904 Rna interference target for treating aids
10/06/2011	US20110243899 Wnt Signaling Inhibitor Comprising Insulin-Like Growth Factor-Binding Protein
10/06/2011	US20110243894 Methods of treating hepatitis c virus infection

1 ... 1534 1535 1536 1537 1538 1539 1540 1541 1542 1543 1544 1545 1546 1547 1548 1549 1550 1551 1552 1553 1554 ... 7860